International Journal for Numerical Methods in Biomedical EngineeringBiophysicsPeer-reviewed journal article
Criterion for assessing accumulated neurotoxicity of alpha-synuclein oligomers in Parkinson's disease
Abstract
The paper introduces a parameter called "accumulated neurotoxicity" of -syn oligomers, which measures the cumulative damage these toxic species inflict on neurons over time, given the years it typically takes for such damage to manifest. A threshold value for accumulated neurotoxicity is estimated, beyond which neuron death is likely. Numerical results suggest that rapid deposition of -syn oligomers into fibrils minimizes toxicity, indicating that the formation of Lewy bodies might play a neuroprotective role. Strategies such as reducing -syn monomer production or enhancing degradation can decrease accumulated toxicity. In contrast, slower degradation (reflected by longer half-lives of monomers and free aggregates) increases toxicity, supporting the idea that impaired protein degradation may contribute to Parkinsons disease progression. The study also examines the sensitivity of accumulated toxicity to different model parameters.
- Citations
- 8
- FWCI
- 4.46
- Field percentile
- top 5%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A criterion characterizing accumulated neurotoxicity of Aβ oligomers in Alzheimer's disease
Andrey V. Kuznetsov·Proceedings of the Royal Society A Mathematical Physical and Engineering SciencesPeer-reviewed·Mar 1, 2025
- Can the lack of fibrillar form of alpha-synuclein in Lewy bodies be explained by its catalytic activity?
I. A. Kuznetsov, A. V. Kuznetsov·bioRxiv·May 9, 2021
- Structure Specific Neuro-toxicity of α-Synuclein Oligomer
A. Mondal, S. Dolui, … N. C. Maiti·bioRxiv·Oct 11, 2020
- DOPAL initiates αSynuclein-mediated impaired proteostasis in neuronal projections leading to enhanced vulnerability in Parkinson's disease.
Anna Masato, Nicoletta Plotegher, … Luigi Bubacco·bioRxiv·Jun 15, 2021
- Mathematical modeling of the role of α-synuclein and dopamine in cell death in Parkinson’s disease provides the molecular basis to the toxicity of different point mutations
Gourvendu Saxena, Utkarsh Khandelwal, Mukesh Doble·bioRxiv·Jul 25, 2019
- WDR44 drives de novo α-synuclein aggregation at the lysosomal membrane and promotes neuronal dysfunction in Parkinson's Disease
Maxime Teixeira, Razan Sheta, … Abid Oueslati·bioRxiv·Apr 7, 2026